Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 6/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | LPL | P06858 | 1/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16426139 | 0.86 | ENPP2 (0.55) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL21308117 | 0.83 | ENPP2 (0.36) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL29209517 | 0.83 | ENPP2 (0.52) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL7657848 | 0.83 | CA2 (0.52) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL16279878 | 0.83 | CA2 (0.52) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL15459219 | 0.83 | CA2 (0.39) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL14435747 | 0.78 | ENPP2 (0.33) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL1277384 | 0.78 | ENPP2 (0.55) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL789866 | 0.78 | ENPP2 (0.70) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL782750 | 0.76 | ENPP2 (0.35) | ENPP2CA4CA6CA5ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116478417-B | Chiral covalent organic framework material based on boric acid ester, chiral separation membrane, preparation method and application thereof | 绍兴文理学院 | 2024-06-28 | — | — | CN | claimed |
| CN-114759196-B | Conjugated microporous polymer electrocatalyst loaded with metal nano particles and preparation method and application thereof | 青岛大学 | 2023-08-29 | — | — | CN | claimed |
| CN-116478417-A | Chiral covalent organic framework material based on boric acid ester, chiral separation membrane, preparation method and application thereof | 绍兴文理学院 | 2023-07-25 | — | — | CN | claimed |
| US-10273339-B2 | Synthesis of a highly crystalline, covalently linked porous network | UNIVERSITY OF SOUTH CAROLINA (US) | 2019-04-30 | — | — | US | claimed |
| US-20150065596-A1 | Synthesis of a Highly Crystalline, Covalently Linked Porous Network | UNIVERSITY OF SOUTH CAROLINA | 2015-03-05 | — | — | US | claimed |
| US-8829065-B2 | Synthesis of a highly crystalline, covalently linked porous network | UNIVERSITY OF SOUTH CAROLINA (US) | 2014-09-09 | — | — | US | claimed |
| US-8258197-B2 | Synthesis of a highly crystalline, covalently linked porous network | UNIVERSITY OF SOUTH CAROLINA (US) | 2012-09-04 | — | — | US | claimed |
| US-20110230678-A1 | ORGANIC FRAMEWORK | INSILICOTECH CO., LTD (KR) | 2011-09-22 | — | — | US | claimed |
| WO-2010056092-A9 | ORGANIC FRAMEWORK | (주)인실리코텍 (KR) | 2010-07-29 | — | — | WO | claimed |
| WO-2010056092-A2 | ORGANIC FRAMEWORK | (주)인실리코텍 (KR) | 2010-05-20 | — | — | WO | claimed |
| US-20090227697-A1 | SYNTHESIS OF A HIGHLY CRYSTALLINE, COVALENTLY LINKED POROUS NETWORK | NATIONAL SCIENCE FOUNDATION | 2009-09-10 | — | — | US | claimed |
| WO-2007098263-A2 | SYNTHESIS OF A HIGHLY CRYSTALLINE, COVALENTLY LINKED POROUS NETWORK | UNIVERSITY OF SOUTH CAROLINA (US) | 2007-08-30 | — | — | WO | claimed |
| US-20260132967-A1 | Absorption Induced Caloric Effects and Uses Thereof | CAMBRIDGE ENTERPRISE LTD (GB) | 2026-05-14 | — | — | US | disclosed |
| EP-4594690-A1 | ABSORPTION INDUCED CALORIC EFFECTS AND USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-12319594-B2 | Composition and method for capture and degradation of PFAS | BATTELLE MEMORIAL INSTITUTE (US) | 2025-06-03 | — | — | US | disclosed |
| US-12071503-B2 | Method for preparing and repairing covalent organic framework materials | ZHEJIANG UNIVERSITY (CN) | 2024-08-27 | — | — | US | disclosed |
| WO-2007098263-A2 | SYNTHESIS OF A HIGHLY CRYSTALLINE, COVALENTLY LINKED POROUS NETWORK | UNIVERSITY OF SOUTH CAROLINA (US) | 2007-08-30 | — | — | WO | disclosed |
| US-6566429-B2 | Mixture of polymer and aromatic boronic compound | UNIVERSITY OF SOUTH CAROLINA | 2003-05-20 | — | — | US | disclosed |
| US-20020173571-A1 | SYNTHESIS AND USE OF NON-HALOGENATED AROMATIC COMPOUNDS AS FLAME RETARDANTS FOR POLYMER-CONTAINING MATERIALS | SOUTH CAROLINA, UNIVERSITY OF | 2002-11-21 | — | — | US | disclosed |
| WO-2000026288-A1 | SYNTHESIS AND USE OF NON-HALOGENATED AROMATIC COMPOUNDS AS FLAME RETARDANTS FOR POLYMER-CONTAINING MATERIALS | UNIVERSITY OF SOUTH CAROLINA (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230678-A1 | ORGANIC FRAMEWORK | MCM4, DBF4, ORC3 | ENPP2 3531/4885CA4 89/4885CA6 729/4885 |
| US-20260132967-A1 | Absorption Induced Caloric Effects and Uses Thereof | SLC2A4, SLC2A1, SLC2A3 | ENPP2 4874/4885CA4 320/4885CA6 609/4885 |
| US-10273339-B2 | Synthesis of a highly crystalline, covalently linked porous network | PARN, PARG, PUF60 | ENPP2 2526/4885CA4 284/4885CA6 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.